The Endocrine Society and The European Society of Endocrinology (ESE) are delighted to announce Anna Gloyn, D.Phil., F.Med.Sci., as the winner of the fifth annual Transatlantic Alliance Award.
The Transatlantic Alliance Award, launched in 2022, recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic—in Europe and the United States.
Gloyn has been honored with this prestigious award for her exceptional work bridging the two continents. A globally recognized geneticist and endocrinologist, she is renowned for pioneering research that uncovers the genetic mechanisms underlying diabetes and advances precision medicine in diabetes care.
"Dr. Gloyn is an internationally recognized leader in endocrinology who has made extraordinary contributions to our understanding of the genetic basis of diabetes and has collaborated with colleagues on both sides of the Atlantic on landmark studies," said Endocrine Society President Carol Lange, Ph.D. "Her ground-breaking contributions to endocrine research across the globe and her outstanding work ethic make her an exceptional candidate for this award."
ESE’s President Wiebke Arlt, M.D., D.Sc., F.R.C.P., F.Med.Sci., said, “I am extremely pleased that Anna Gloyn is our 2026 Award winner. She is an inspiring example for emerging researchers who has shown exemplary leadership, and her contribution to endocrine and diabetes research has been invaluable. Her career embodies true transatlantic scientific exchange, reflected in her contributions to major international research alliances, editorial boards and her receipt of multiple accolades.”
Gloyn commented, “For me, science is all about collaboration, and I continue to be fortunate to collaborate with so many incredible clinicians and scientists across Europe and the United States. I am honored to be recognized by both societies for doing what I truly love and would like to thank all my trainees, mentors and collaborators for enriching my scientific journey.”
She continued, "I believe collaboration results in more than the sum of the parts. I learnt this as a trainee funded by an EU Horizon 2020 team science project and subsequently through multiple international consortia, which bring people from both sides of the Atlantic together to move the needle in our collective efforts to improve the lives of people with diabetes.”
Gloyn is Professor of Pediatrics at Stanford University in Stanford, Calif. She earned her D.Phil. at the University of Oxford in Oxford, England, followed by post-doctoral training at the University of Exeter in Exeter, England, and the University of Pennsylvania in Philadelphia, Penn. Her early research centered on the impact of genetic variation in KATP channel genes, first in type 2 diabetes and later in neonatal diabetes.
In 2004, she returned to Oxford to establish an independent research program dedicated to elucidating beta-cell biology through functional characterization of genetic variants that cause monogenic diabetes. She is a member of the ClinGen expert review panel for monogenic diabetes and recently co-led the Precision Diagnostics working group for the International Precision Medicine Diabetes Initiative.
Gloyn’s major focus for the past ten years has been on translating discoveries from genome-wide association studies into biological and clinical insights. Her research combines genetic discovery and functional genomics with clinical phenotyping and disease modeling in human cell models to elucidate how changes in DNA sequence alter diabetes risk. Highly collaborative, she plays roles in multiple international consortia, including the Accelerated Medicines Partnership for Common Metabolic Disease (AMP-CMD) and the Human Islet Research Network (HIRN).
Gloyn has received multiple national and international awards for her research, including the European Association for the Study of Diabetes (EASD) Rising Star (2005) and Minkowski (2014) awards and the American Diabetes Association Outstanding Scientific Achievement Award (2022). In 2025, she was elected to the Academy of Medical Sciences in the United Kingdom.
Gloyn will present her award lecture at the European Society of Endocrinology’s Annual Congress, the European Congress of Endocrinology (ECE) 2026, which is taking place from May 9-12 in Prague, Czech Republic.
Nominations for the 2027 Transatlantic Alliance Award will open early next year.
About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.
Colleen Williams Associate Director, Communications and Media Relations Phone: (202)-971-3611 [email protected]
Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
